SCHEMBL18256199

SCHEMBL18256199

COC1(CCC(C)C)CCC(F)(F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834090 0.78
SCHEMBL18256184 0.75 OPRM1 (0.33)
SCHEMBL18091507 0.73 CYP4F2 (0.33)
SCHEMBL17835218 0.73
SCHEMBL18091490 0.72
SCHEMBL23194411 0.71
SCHEMBL17818940 0.71 SLC6A4 (0.31)
SCHEMBL18091703 0.71
SCHEMBL13814776 0.71 CETP (0.33)
Hydrochloric Acid SCHEMBL17818921 0.70 SLC6A4 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392345-B2 Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2019-08-27 US disclosed
US-20180148409-A1 CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF UBE CORPORATION (JP) 2018-05-31 US disclosed
US-20180148409-A1 CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF UBE CORPORATION (JP) 2018-05-31 US disclosed
EP-3299357-A1 CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2018-03-28 EP disclosed
WO-2016186184-A1 CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF 株式会社 三和化学研究所 2016-11-24 WO disclosed